1. Home
  2. MXCT vs BYND Comparison

MXCT vs BYND Comparison

Compare MXCT & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • BYND
  • Stock Information
  • Founded
  • MXCT 1999
  • BYND 2009
  • Country
  • MXCT United States
  • BYND United States
  • Employees
  • MXCT N/A
  • BYND N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BYND Packaged Foods
  • Sector
  • MXCT Health Care
  • BYND Consumer Staples
  • Exchange
  • MXCT Nasdaq
  • BYND Nasdaq
  • Market Cap
  • MXCT 239.2M
  • BYND 258.5M
  • IPO Year
  • MXCT 2021
  • BYND 2019
  • Fundamental
  • Price
  • MXCT $2.24
  • BYND $3.52
  • Analyst Decision
  • MXCT Strong Buy
  • BYND Sell
  • Analyst Count
  • MXCT 1
  • BYND 3
  • Target Price
  • MXCT $9.00
  • BYND $4.00
  • AVG Volume (30 Days)
  • MXCT 717.0K
  • BYND 1.6M
  • Earning Date
  • MXCT 08-06-2025
  • BYND 08-06-2025
  • Dividend Yield
  • MXCT N/A
  • BYND N/A
  • EPS Growth
  • MXCT N/A
  • BYND N/A
  • EPS
  • MXCT N/A
  • BYND N/A
  • Revenue
  • MXCT $37,675,000.00
  • BYND $319,580,000.00
  • Revenue This Year
  • MXCT $8.82
  • BYND N/A
  • Revenue Next Year
  • MXCT $21.12
  • BYND $3.36
  • P/E Ratio
  • MXCT N/A
  • BYND N/A
  • Revenue Growth
  • MXCT N/A
  • BYND N/A
  • 52 Week Low
  • MXCT $2.00
  • BYND $2.23
  • 52 Week High
  • MXCT $5.20
  • BYND $9.24
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 48.76
  • BYND 60.00
  • Support Level
  • MXCT $2.16
  • BYND $3.45
  • Resistance Level
  • MXCT $2.29
  • BYND $3.67
  • Average True Range (ATR)
  • MXCT 0.12
  • BYND 0.15
  • MACD
  • MXCT 0.01
  • BYND -0.01
  • Stochastic Oscillator
  • MXCT 71.20
  • BYND 68.18

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: